Near-triploidy and near-tetraploidy in hematological malignancies and mutation of the p53 gene

Clinical and Laboratory Haematology

Volumn 26, Issue 1, 2004, Pages 25-30

  Watanabe, A ^a   Inokuchi, K ^a   Yamaguchi, H ^a   Mizuki, T ^a   Tanosaki, S ^a   Shimada, T ^a   Dan, K ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

B cell neoplasms; Hyperdiploid; p53; Tetraploid; Triploid

Indexed keywords

PROTEIN P53;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLELE; ARTICLE; AUTOSOME ABERRATION; B CELL LYMPHOMA; CHROMOSOME IDENTIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DIPLOIDY; FEMALE; GENE DELETION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; MALE; MUTATOR GENE; MYELODYSPLASTIC SYNDROME; POINT MUTATION; PRIORITY JOURNAL; PROGNOSIS; T CELL LYMPHOMA; TETRAPLOIDY; TRIPLOIDY; TUMOR SUPPRESSOR GENE;

ADULT; CHROMOSOME DISORDERS; FEMALE; GENE DELETION; GENES, P53; HEMATOLOGIC NEOPLASMS; HODGKIN DISEASE; HUMANS; KARYOTYPING; LEUKEMIA, B-CELL; LEUKEMIA, T-CELL; MALE; POLYPLOIDY; PROGNOSIS;

EID: 1242294602     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0141-9854.2003.00574.x     Document Type: Article

References (18)

1. Abo J., Inokuchi K., Dan K. & Nomura T. (1993) p53 and N-ras mutations in two new leukemia cell lines established from a patient with multilineage CD7-positive acute leukemia. Blood 82, 2829-2836.
2. Berger R., Flandrin G., Berheim A., Le Coniat M., Vecchione D., Pacot A., Derre J., Daniel M.T., Valensi F., Siguax F. & Ochoa-Noguera M.E. (1987) Cytogenetic studies on 519 consecutive de novo acute nonlymphocytic leukemias. Cancer Genetics & Cytogenetics 29, 9-21.
3. Cross S.M., Sanchez C.A., Morgan C.A., Shimke M.K., Ramel S., Idzerda R.L., Raskind W.H. & Reid B.J. (1995) A p53-dependent mouse spindle checkpoint. Science 267, 1353-1356.
4. Forestier R., Johansson B., Borgstoem G., Kerndrup G., Johannsson J. & Heim S. (2000) Cytogenic findings in a population-based series of 787 childhood acute lymphoblastic leukemia from the Nordic countries. European Journal of Hematology 64, 194-200.
5. Group Francais de Cytogenetique (1996) Cytogenetic abnormalities in adult lymphoblastic leukemia: correlations with hematologic findings and outcome. A collaborative study of the Group Francais de Cytogenetique Hematologique. Blood 87, 3135-3142.
6. Hartwell L.H. & Kastan M.B. (1994) Cell cycle control and cancer. Science 266, 1821-1827.
7. Heerema N.A., Sather H.N., Sensel M.G., Zhang T., Hutchinson R.J., Nachman J.B., Lange B.J., Steinherz P.C., Bostrrom B.C., Reaman G.H., Gaynon P.S. & Uckun F.M. (2000) Prognostic impact of trisomies of chromosomes 10. 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (>50 chromosomes). Journal of Clinical Oncology 18, 1876-1887.
8. Heim S. & Mitelman F. (1986) Numerical chromosome aberration in human neoplasia. Cancer Genetics & Cytogenetics 22, 99-108.
9. ISCN (1995) Guidelines for cancer cytogenetics. In: Supplement to an International System for Human Cytogenetic Nomenclature (ed. F. Mitelman). Karger. Basel.
10. Kaplan E.L. & Meier P. (1958) Non parametric estimation for incomplete observations. Journal of the American Statistical Association 53, 457-481.
11. Kropveld A., Rozemuller E.H., Leppers F.G.J., Scheidel K.C., de Weger R.A., Koole R., Hordijk G.J., Slootweg P.J. & Tilanus M.G.J. (1999) Sequencing analysis of RNA and DNA of exon 1 through 11 shows p53 gene alterations to be present in almost 100% of the head and neck squamous cell cancers. Laboratory Investigation 79, 347-353.
12. Nakamura K., Inokuchi K. & Dan K. (2001) Abnormalities of the p53. N-ras, DCC and FLT-3 Genes in myelodysplastic syndromes. Journal of Nippon Medical School 68, 143-148.
13. Preudhomme C. & Fenaux P. (1997) The clinical significance of mutations of the p53 tumor suppressor gene in haematological malignancies. British Journal of Haematology 98, 502-511.
14. Pui C.H., Carroll A.J., Head D., Raimondi S.C., Shuster J.J., Crist W.M., Link M.P., Borowitz M.J., Behm F.G., Land V.J., Nash M.B., Pullen D.J. & Look A.T. (1990) Near-triploid and near-tetraploid acute lymphoblastic leukemia of childhood. Blood 76, 590-596.
15. Secker-Walker L.M., Lawler S.D. & Hardisty R.M. (1978) Prognostic implications of chromosomal findings in acute lymphoblastic leukemia at diagnosis. British Medical Journal 2, 1529-1530.
16. Van Oijen M.G.C.T. & Slootweg P.J. (2000) Gain-of-function mutations in the tumor suppressor gene p53. Clinical Cancer Research 6, 2138-2145.
17. Waldman T., Christoph L., Kenneth W. & Vogelstein K. (1996) Uncoupling of S phase and mitosis induced by anticancer agents in cell lacking p21. Nature 381, 713-716.
18. Williams D.L., Tsiatis A., Brodeur G.M., Look A.T., Melvin S.L., Bowman W.P., Kalwinsky D.K., Rivera G. & Dahl G.V. (1982) Prognostic importance of chromosome number in 136 untreated children with acute lymphoblastic leukemia. Blood 60, 864-871.